Revance Welcomes Steve Kreider as New Chief Revenue Officer for Aesthetics

Revance Welcomes Steve Kreider as Chief Revenue Officer

Revance Therapeutics, known for its innovative role in the aesthetics and skincare industry, has announced a significant leadership change that could shape its future direction. Starting immediately, Steve Kreider has been appointed as the Executive Vice President and Chief Revenue Officer for the company's Aesthetics and Therapeutics divisions. This pivotal move reflects Revance's strategic approach to enhance its commercial initiatives and ultimately bolster its market standing amid rising competition.

Expanding Leadership with Experience

In his newly created position, Kreider will oversee Revance's U.S. sales and revenue strategies across both the Aesthetics and Therapeutics sectors. His extensive background includes over 20 years in commercial leadership roles, making him a vital asset for Revance as it aims to drive sustainable growth. He previously served as the Senior Vice President for North America and Global Marketing at Cutera, where he played an instrumental role during a transformative phase for the company. Kreider's impressive track record of successful product launches and brand transformations in the aesthetics realm aligns perfectly with Revance's mission for innovation and market expansion.

Nadeem Moiz, Chief Executive Officer of Revance, expressed enthusiasm regarding Kreider's appointment, stating, "Steve is a proven commercial leader with deep experience across aesthetics and therapeutics." Highlighting Kreider's ability to build high-performing teams and navigate complex market landscapes, Moiz's endorsement sets a positive tone for Kreider’s entry into the leadership team.

Kreider's Vision for Growth

Upon his appointment, Steve Kreider emphasized the immense potential of Revance's offerings. He stated, "Revance has a powerful portfolio and a significant opportunity to accelerate growth across both aesthetics and therapeutics." Kreider's focus will be on enhancing the company's commercial execution and expanding its market impact through innovative strategies and capabilities. His understanding of market needs and consumer demands will be crucial as Revance seeks to maximize its long-term business potential.

Revance currently boasts a diverse array of products tailored to meet the evolving needs of customers worldwide, including leading aesthetics solutions like DAXXIFY® and a comprehensive skincare portfolio comprising brands such as PanOxyl® and Blue Lizard®. Kreider's mission will undoubtedly include integrating sales strategies across these categories and fostering deeper engagement with healthcare providers and customers.

About Revance

As a fast-growing global leader in aesthetics and skincare, Revance is committed to revolutionizing the market by offering innovative products that cater to clients at every life stage. The company emphasizes skin science as a vital component of its product development, ensuring that advancements translate into real-world benefits for consumers and practitioners alike. In a field where competition continues to intensify, Revance stands out for its commitment to quality and cutting-edge advancements.

Kreider's leadership is poised to invigorate the company during a time when adaptability and strategic insight are paramount. With fresh leadership and a clear vision, Revance aims to solidify its position as a frontrunner in aesthetics and therapeutic markets. As the company navigates this new chapter in its journey, stakeholders and customers alike will be watching with great interest to see how Kreider's experience will shape the future of Revance and its initiatives.